FIELD: pharmacy.
SUBSTANCE: invention relates to 5-bromonicotinic acid derivatives: , where R1 is hydrogen; R2 is 4-methoxy-6-methyl-1,3,5-triazile-2, or a hydrogen proton or a 2-methyl-1,2,4-triazolyl-1. The compounds can be used in clinical practice for cardiac rhythm correction.
EFFECT: creation of a new compound with anti-arrhythmic activity.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
ANTIARRHYTHMIC PREPARATION | 1999 |
|
RU2185159C2 |
AGENT EXHIBITING ANTIARRHYTHMIC ACTIVITY | 2014 |
|
RU2565404C1 |
ANTIARRHYTHMIC AGENT | 1984 |
|
RU2028144C1 |
DERIVATIVE OF 4-HYDROXYBUTYRIC ACID BENZYLAMIDE SHOWING LOCAL ANESTHETIC, ANTIARRHYTHMIC, ANTIANGIAL AND ANTINECROTIC ACTIVITY | 1988 |
|
SU1601984A1 |
PHARMACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF CHRONIC DISORDERS OF VEGETATIVE REGULATION OF HEART RHYTHM AND METHOD OF PREVENTION AND TREATMENT BY MEANS OF PHARMACEUTICAL COMBINATION | 2012 |
|
RU2493836C1 |
USE OF 2-METHYLENE-1,3-DINITROXYPROPANE AS ANTI-ISCHEMIC AGENT | 2015 |
|
RU2580929C1 |
ANTIARRHYTHMIC DRUG | 2017 |
|
RU2664668C1 |
APPLICATION OF GLUTARIC ACID DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AS ANTIARRHYTHMIC DRUG | 2008 |
|
RU2373934C1 |
Authors
Dates
2017-04-25—Published
2015-09-09—Filed